Selvas Healthcare, Inc. (208370.KQ) Stock
Selvas Healthcare, Inc.

Company profile
Selvas Healthcare reported revenue of 30.82 billion KRW for fiscal year 2025, down 2.8% from fiscal year 2024, and net income of 3.89 billion KRW. That is a net profit margin of 12.6% for fiscal year 2025. Its largest business segment, Medical Diagnosis Division, brought in 57% of segment revenue in fiscal year 2024; South Korea was the largest region with 35%. Our analysis of its filings shows revenue growing from 29.81 billion KRW in fiscal year 2023 to 30.82 billion KRW in fiscal year 2025, 1.7% a year on average. Selvas Healthcare reports about 129 full-time employees.
Figures from company filings; latest fiscal year ended December 31, 2025.
About Selvas Healthcare, Inc.
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are used in hospitals, medical facilities, doctor's offices, weight loss centers, Fitness Centers, nursing homes, public health facilities, and retail locations. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1993 and is headquartered in Daejeon, South Korea.
Largest shareholders
- Selvas Ai Inc.38.08%
- Credo Co Ltd1.38%
- Byeong-Tak Yoo0.1899 %0.19%
- Selvas Healthcare, Inc.0.09%
Share of the company, as of September 25, 2026
Leadership
- Chul-Joong Kwon — CEO & Director, 60
- Byung-Tak Yoo — CEO & Director, 51
- Woo-Jae Lee — MD & Chief of Marketing Office, 56
- Haeseok Lee — Executive Director, 45
- Min-Cheol Kwak — Executive Director, 50
How much revenue does Selvas Healthcare make?
Selvas Healthcare reported 30.82 billion KRW in revenue for fiscal year 2025, down 2.8% from 31.70 billion KRW in fiscal year 2024.
What is Selvas Healthcare's largest business segment?
Medical Diagnosis Division, with 19.42 billion KRW or 57% of segment revenue in fiscal year 2024. Next: Assistive Technology Division (43%).
Where does Selvas Healthcare make most of its revenue?
South Korea: 35% of revenue by region in fiscal year 2024, followed by Oceania (28%).
What companies are similar to Selvas Healthcare?
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Rokit Healthcare Inc. (376900.KQ), Humedix Co., Ltd. (200670.KQ), Synergy Innovation Co., Ltd. (048870.KQ), PanGen Biotech Inc. (222110.KQ).
Company Information
Contact & Links
Data as of .
How to cite: DataPorium, “Selvas Healthcare, Inc. (208370.KQ)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/208370.KQ